Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$2.46 - $8.74 $1.89 Million - $6.72 Million
-769,387 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $133,365 - $245,548
-26,150 Reduced 3.29%
769,387 $6.57 Million
Q2 2021

Aug 13, 2021

BUY
$3.95 - $6.88 $3.14 Million - $5.47 Million
795,537 New
795,537 $5.09 Million
Q3 2020

Nov 13, 2020

SELL
$1.76 - $2.17 $588,783 - $725,943
-334,536 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$1.75 - $2.65 $176,317 - $266,995
-100,753 Reduced 23.15%
334,536 $706,000
Q1 2020

May 13, 2020

BUY
$1.15 - $3.29 $500,582 - $1.43 Million
435,289 New
435,289 $862,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.